How does MDIN's PB Ratio compare to its peers?

Insufficient data to calculate MDIN's Price-To-Book Ratio vs. peers for valuation analysis.

How does MDIN's PB Ratio compare vs other companies in the US Healthcare Services Industry?

Insufficient data to calculate MDIN's Price-To-Book Ratio vs. industry for valuation analysis.

What is MDIN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MDIN's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MDIN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MDIN's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MedGen OTCPK:MDIN Stock Report

Last Price

US$0.000001

Market Cap

US$3.0k

7D

0%

1Y

n/a

Updated

11 Feb, 2025

Data

Company Financials

MedGen, Inc.

OTCPK:MDIN Stock Report

Market Cap: US$3.0k

MDIN Stock Overview

As of June 25, 2020, 9430075 Canada Ltd. was acquired by MedGen, Inc. More details

MDIN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($3K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

MedGen, Inc. Competitors

UpHealth

OTCPK:UPHL

US$3.8k

SOAFEE

OTCPK:SOFE

US$45.1k

ThermoGenesis Holdings

OTCPK:THMO

US$4.8k

Motus GI Holdings

OTCPK:MOTS

US$719.0

Price History & Performance

Summary of share price highs, lows and changes for MedGen
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MDIN	US Healthcare Services	US Market
7D	0%	6.0%	0.2%
1Y	n/a	10.1%	23.1%

Return vs Industry: Insufficient data to determine how MDIN performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how MDIN performed against the US Market.

Price Volatility

Is MDIN's price volatile compared to industry and market?
MDIN volatility
MDIN Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	10.6%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.3%
10% least volatile stocks in US Market	3.0%

Stable Share Price: MDIN's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MDIN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	n/a	n/a	www.magnifind.ca

As of June 25, 2020, 9430075 Canada Ltd. was acquired by MedGen, Inc. in a reverse merger transaction. 9430075 Canada Ltd.

MedGen, Inc. Fundamentals Summary

How do MedGen's earnings and revenue compare to its market cap?
MDIN fundamental statistics
Market cap	US$3.01k
Earnings (TTM)	-US$15.54k
Revenue (TTM)	US$1.05k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is MDIN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDIN income statement (TTM)
Revenue	US$1.05k
Cost of Revenue	US$0
Gross Profit	US$1.05k
Other Expenses	US$16.59k
Earnings	-US$15.54k

Last Reported Earnings

Dec 31, 2019

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MDIN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/11 03:32
End of Day Share Price	2024/12/11 00:00
Earnings	2019/12/31
Annual Earnings	2019/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedGen, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.